RESUMO
A case of dyslipoproteinaemia of type V in a woman suffering from primary hypothyroidism, florid diabetes mellitus and obesity is reported. The case is commented on in general and as regards possible correlations between the diseases and the dyslipoproteinaemic picture. The various therapeutic treatment employed and results are also reported.
Assuntos
Diabetes Mellitus/sangue , Hipotireoidismo/sangue , Lipídeos/sangue , Obesidade , Idoso , Colesterol/sangue , Clofibrato/uso terapêutico , Complicações do Diabetes , Diabetes Mellitus/tratamento farmacológico , Feminino , Glibureto/uso terapêutico , Humanos , Hipotireoidismo/complicações , Hipotireoidismo/tratamento farmacológico , Paraproteinemias/complicações , Paraproteinemias/tratamento farmacológico , Tiroxina/uso terapêutico , Triglicerídeos/sangueRESUMO
The association of lithium carbonate and antiblastic drugs has been studied in 22 patients suffering from tumours to see whether it was able to prevent or attenuate the neutropenising effect and establish whether its protection action on leucocytaemia was not just transitory but was maintained for prolonged treatment also. Patients were submitted to four oncolytic treatment cycles during which administration with LiCO3 was associated with the first and third cycles (LNLN sequence) in 14 patients and with the second and fourth (NLNL sequence) in the other 8. Statistical analysis of the results obtained confirmed that lithium carbonate performs a protective action with respect to antiblastic-induced neutropenia and that the action is long term. The drop in monocytes also seems to diminish after administration of lithium carbonate.